Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Highlights

  • Highlights
    Selected Articles from This Issue
    Clin Cancer Res February 15 2021 27 (4) 903-903;

CCR Translations

  • CCR Translations
    Osimertinib plus Ramucirumab: The Best of Both Worlds?
    Edward B. Garon
    Clin Cancer Res February 15 2021 27 (4) 905-907; DOI:10.1158/1078-0432.CCR-20-4026

  • CCR Translations
    Combined PD-1/VEGFR Blockade: A New Era of Treatment for Hepatocellular Cancer
    David J. Pinato, Petros Fessas, Alessio Cortellini and Lorenza Rimassa
    Clin Cancer Res February 15 2021 27 (4) 908-910; DOI:10.1158/1078-0432.CCR-20-4069

  • CCR Translations
    Predicting CAR-T cell Immunotherapy Success through ImmunoPET
    Alessia Volpe, Veronica L. Nagle, Jason S. Lewis and Vladimir Ponomarev
    Clin Cancer Res February 15 2021 27 (4) 911-912; DOI:10.1158/1078-0432.CCR-20-4297

  • CCR Translations
    Transcription Strikes Back: Clinical Utility of Lung Adenocarcinoma Subtypes
    Ferdinandos Skoulidis
    Clin Cancer Res February 15 2021 27 (4) 913-915; DOI:10.1158/1078-0432.CCR-20-3914

CCR Perspectives in Regulatory Science and Policy

  • CCR Perspectives in Regulatory Science and Policy | Free Article
    FDA Oncology Center of Excellence Project Renewal: Engaging the Oncology Community to Update Product Labeling for Older Oncology Drugs
    Paul G. Kluetz, Patricia Keegan, George D. Demetri, Katherine Thornton, Joohee Sul, Janice Kim, Harvey Katzen, Laurie Beth Burke, R. Donald Harvey, Elleni Alebachew, Sundeep Agrawal, Abhilasha Nair, Martha Donoghue, William F. Pierce, Stacy S. Shord, Jennifer J. Gao and Richard Pazdur
    Clin Cancer Res February 15 2021 27 (4) 916-921; DOI:10.1158/1078-0432.CCR-20-3213

CCR Drug Updates

  • CCR Drug Updates
    FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma
    Elaine Chang, Chana Weinstock, Lijun Zhang, Rosane Charlab, Sarah E. Dorff, Yutao Gong, Vicky Hsu, Fang Li, Tiffany K. Ricks, Pengfei Song, Shenghui Tang, Peter E. Waldron, Jingyu Yu, Eias Zahalka, Kirsten B. Goldberg, Richard Pazdur, Marc R. Theoret, Amna Ibrahim and Julia A. Beaver
    Clin Cancer Res February 15 2021 27 (4) 922-927; DOI:10.1158/1078-0432.CCR-20-2275

  • CCR Drug Updates
    FDA Approval Summary: Entrectinib for the Treatment of NTRK gene Fusion Solid Tumors
    Leigh Marcus, Martha Donoghue, Stephanie Aungst, Claire E. Myers, Whitney S. Helms, Guoxiang Shen, Hong Zhao, Olen Stephens, Patricia Keegan and Richard Pazdur
    Clin Cancer Res February 15 2021 27 (4) 928-932; DOI:10.1158/1078-0432.CCR-20-2771

Perspectives

  • Perspectives
    Optimizing the Use of Telemedicine in Oncology Care: Postpandemic Opportunities
    Karen E. Knudsen, Cheryl Willman and Robert Winn
    Clin Cancer Res February 15 2021 27 (4) 933-936; DOI:10.1158/1078-0432.CCR-20-3758

  • Perspectives
    The Challenge of Combining Chemo- and Radiotherapy with Checkpoint Kinase Inhibitors
    Linda van Bijsterveldt, Samuel C. Durley, Tim S. Maughan and Timothy C. Humphrey
    Clin Cancer Res February 15 2021 27 (4) 937-962; DOI:10.1158/1078-0432.CCR-20-3358

  • Perspectives | AuthorChoice
    WORLD CANCER RESEARCH DAY: A Call to Action for a Coordinated International Research Effort to Prevent, Diagnose, and Treat Cancer
    Marta Puyol, Joan Seoane, Esther Aguilar, Lisa B. Vozza, Isabel Orbe, Katherine H. Crawford, Ana Fernández, Freddie Bray, Sonali E. Johnson and Satish Gopal
    Clin Cancer Res February 15 2021 27 (4) 963-966; DOI:10.1158/1078-0432.CCR-20-2978

Research Briefs: Clinical Trial Brief Report

  • Research Briefs: Clinical Trial Brief Report
    A Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast Cancer
    Smita Bhatia, Melanie R. Palomares, Lindsey Hageman, Yanjun Chen, Wendy Landier, Kandice Smith, Heidi Umphrey, Caroline A. Reich, Kathryn W. Zamora, Saro H. Armenian, Therese B. Bevers, Anne Blaes, Tara Henderson, David Hodgson, Melissa M. Hudson, Larissa A. Korde, Susan A. Melin, Sofia D. Merajver, Linda Overholser, Sandhya Pruthi, F. Lennie Wong and Judy E. Garber
    Clin Cancer Res February 15 2021 27 (4) 967-974; DOI:10.1158/1078-0432.CCR-20-3609

Clinical Trials: Targeted Therapy

  • Clinical Trials: Targeted Therapy
    Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer (NeoSTOP)
    Priyanka Sharma, Bruce F. Kimler, Anne O'Dea, Lauren Nye, Yen Y. Wang, Rachel Yoder, Joshua M. Staley, Lindsey Prochaska, Jamie Wagner, Amanda L. Amin, Kelsey Larson, Christa Balanoff, Manana Elia, Gregory Crane, Sheshadri Madhusudhana, Marc Hoffmann, Maureen Sheehan, Roberto Rodriguez, Karissa Finke, Rajvi Shah, Deepti Satelli, Anuj Shrestha, Larry Beck, Richard McKittrick, Robert Pluenneke, Vinay Raja, Venkatadri Beeki, Larry Corum, Jaimie Heldstab, Stephanie LaFaver, Micki Prager, Milind Phadnis, Dinesh Pal Mudaranthakam, Roy A. Jensen, Andrew K. Godwin, Roberto Salgado, Kathan Mehta and Qamar Khan
    Clin Cancer Res February 15 2021 27 (4) 975-982; DOI:10.1158/1078-0432.CCR-20-3646

  • Clinical Trials: Targeted Therapy
    Clinical Efficacy and Molecular Response Correlates of the WEE1 Inhibitor Adavosertib Combined with Cisplatin in Patients with Metastatic Triple-Negative Breast Cancer
    Tanya E. Keenan, Tianyu Li, Tuulia Vallius, Jennifer L. Guerriero, Nabihah Tayob, Bose Kochupurakkal, Janae Davis, Ricardo Pastorello, Rie K. Tahara, Leilani Anderson, Jake Conway, Meng X. He, Erin Shannon, Robert E. Godin, Peter K. Sorger, Alan D'Andrea, Beth Overmoyer, Eric P. Winer, Elizabeth A. Mittendorf, Eliezer M. Van Allen, Geoffrey I. Shapiro and Sara M. Tolaney
    Clin Cancer Res February 15 2021 27 (4) 983-991; DOI:10.1158/1078-0432.CCR-20-3089

  • Clinical Trials: Targeted Therapy
    Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non–small Cell Lung Cancer
    Helena A. Yu, Luis G. Paz-Ares, James Chih-Hsin Yang, Ki Hyeong Lee, Pilar Garrido, Keunchil Park, Joo-Hang Kim, Dae Ho Lee, Huzhang Mao, Sameera R. Wijayawardana, Ling Gao, Rebecca R. Hozak, Bo H. Chao and David Planchard
    Clin Cancer Res February 15 2021 27 (4) 992-1002; DOI:10.1158/1078-0432.CCR-20-1690

Clinical Trials: Immunotherapy

  • Clinical Trials: Immunotherapy
    Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
    Jianming Xu, Jie Shen, Shanzhi Gu, Yun Zhang, Lihua Wu, Jian Wu, Guoliang Shao, Yanqiao Zhang, Li Xu, Tao Yin, Jingfeng Liu, Zhenggang Ren, Jianping Xiong, Xianhai Mao, Ling Zhang, Jiayin Yang, Lequn Li, Xiaoming Chen, Zhiming Wang, Kangsheng Gu, Xi Chen, Zhanyu Pan, Kuansheng Ma, Xinmin Zhou, Zujiang Yu, Enxiao Li, Guowen Yin, Xiao Zhang, Shuni Wang and Quanren Wang
    Clin Cancer Res February 15 2021 27 (4) 1003-1011; DOI:10.1158/1078-0432.CCR-20-2571

  • Clinical Trials: Immunotherapy
    A Phase I Trial of Talimogene Laherparepvec in Combination with Neoadjuvant Chemotherapy for the Treatment of Nonmetastatic Triple-Negative Breast Cancer
    Hatem Soliman, Deanna Hogue, Hyo Han, Blaise Mooney, Ricardo Costa, Marie C. Lee, Bethany Niell, Angela Williams, Alec Chau, Shannon Falcon, Nazanin Khakpour, Robert J. Weinfurtner, Susan Hoover, John Kiluk, Marilin Rosa, Hung Khong and Brian Czerniecki
    Clin Cancer Res February 15 2021 27 (4) 1012-1018; DOI:10.1158/1078-0432.CCR-20-3105

  • Clinical Trials: Immunotherapy
    Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti–PD-(L)1 Therapy
    Matthew D. Hellmann, Pasi A. Jänne, Mateusz Opyrchal, Navid Hafez, Luis E. Raez, Dmitry I. Gabrilovich, Fang Wang, Jane B. Trepel, Min-Jung Lee, Akira Yuno, Sunmin Lee, Susan Brouwer, Serap Sankoh, Lei Wang, David Tamang, Emmett V. Schmidt, Michael L. Meyers, Suresh S. Ramalingam, Elaine Shum and Peter Ordentlich
    Clin Cancer Res February 15 2021 27 (4) 1019-1028; DOI:10.1158/1078-0432.CCR-20-3305

  • Clinical Trials: Immunotherapy | AuthorChoice
    Multicenter Phase I/II Study of Nivolumab Combined with Paclitaxel Plus Ramucirumab as Second-line Treatment in Patients with Advanced Gastric Cancer
    Takako Eguchi Nakajima, Shigenori Kadowaki, Keiko Minashi, Tomohiro Nishina, Takeharu Yamanaka, Yuichiro Hayashi, Naoki Izawa, Kei Muro, Shuichi Hironaka, Takeshi Kajiwara and Yutaka Kawakami
    Clin Cancer Res February 15 2021 27 (4) 1029-1036; DOI:10.1158/1078-0432.CCR-20-3559

  • Clinical Trials: Immunotherapy
    Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical Trial
    Anne Montfort, Thomas Filleron, Mathieu Virazels, Carine Dufau, Jean Milhès, Cécile Pagès, Pascale Olivier, Maha Ayyoub, Muriel Mounier, Amélie Lusque, Stéphanie Brayer, Jean-Pierre Delord, Nathalie Andrieu-Abadie, Thierry Levade, Céline Colacios, Bruno Ségui and Nicolas Meyer
    Clin Cancer Res February 15 2021 27 (4) 1037-1047; DOI:10.1158/1078-0432.CCR-20-3449

  • Clinical Trials: Immunotherapy
    Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
    Lakshmi Nayak, Annette M. Molinaro, Katherine Peters, Jennifer L. Clarke, Justin T. Jordan, John de Groot, Leia Nghiemphu, Thomas Kaley, Howard Colman, Christine McCluskey, Sarah Gaffey, Timothy R. Smith, David J. Cote, Mariano Severgnini, Jennifer H. Yearley, Qing Zhao, Wendy M. Blumenschein, Dan G. Duda, Alona Muzikansky, Rakesh K. Jain, Patrick Y. Wen and David A. Reardon
    Clin Cancer Res February 15 2021 27 (4) 1048-1057; DOI:10.1158/1078-0432.CCR-20-2500

Precision Medicine and Imaging

  • Precision Medicine and Imaging | AuthorChoice
    Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET
    Federico Simonetta, Israt S. Alam, Juliane K. Lohmeyer, Bita Sahaf, Zinaida Good, Weiyu Chen, Zunyu Xiao, Toshihito Hirai, Lukas Scheller, Pujan Engels, Ophir Vermesh, Elise Robinson, Tom Haywood, Ataya Sathirachinda, Jeanette Baker, Meena B. Malipatlolla, Liora M. Schultz, Jay Y. Spiegel, Jason T. Lee, David B. Miklos, Crystal L. Mackall, Sanjiv S. Gambhir and Robert S. Negrin
    Clin Cancer Res February 15 2021 27 (4) 1058-1068; DOI:10.1158/1078-0432.CCR-20-2770

  • Precision Medicine and Imaging
    Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer
    Sara A. Väyrynen, Jinming Zhang, Chen Yuan, Juha P. Väyrynen, Andressa Dias Costa, Hannah Williams, Vicente Morales-Oyarvide, Mai Chan Lau, Douglas A. Rubinson, Richard F. Dunne, Margaret M. Kozak, Wenjia Wang, Diana Agostini-Vulaj, Michael G. Drage, Lauren Brais, Emma Reilly, Osama Rahma, Thomas Clancy, Jiping Wang, David C. Linehan, Andrew J. Aguirre, Charles S. Fuchs, Lisa M. Coussens, Daniel T. Chang, Albert C. Koong, Aram F. Hezel, Shuji Ogino, Jonathan A. Nowak and Brian M. Wolpin
    Clin Cancer Res February 15 2021 27 (4) 1069-1081; DOI:10.1158/1078-0432.CCR-20-3141

  • Precision Medicine and Imaging
    Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples
    Alexander Semaan, Vincent Bernard, Jaewon J. Lee, Justin W. Wong, Jonathan Huang, Daniel B. Swartzlander, Bret M. Stephens, Maria E. Monberg, Brian R. Weston, Manoop S. Bhutani, Kyle Chang, Paul A. Scheet, Anirban Maitra, Yasminka A. Jakubek and Paola A. Guerrero
    Clin Cancer Res February 15 2021 27 (4) 1082-1093; DOI:10.1158/1078-0432.CCR-20-2667

  • Precision Medicine and Imaging
    Discrimination of Breast Cancer from Healthy Breast Tissue Using a Three-component Diffusion-weighted MRI Model
    Maren M. Sjaastad Andreassen, Ana E. Rodríguez-Soto, Christopher C. Conlin, Igor Vidić, Tyler M. Seibert, Anne M. Wallace, Somaye Zare, Joshua Kuperman, Boya Abudu, Grace S. Ahn, Michael Hahn, Neil P. Jerome, Agnes Østlie, Tone F. Bathen, Haydee Ojeda-Fournier, Pål Erik Goa, Rebecca Rakow-Penner and Anders M. Dale
    Clin Cancer Res February 15 2021 27 (4) 1094-1104; DOI:10.1158/1078-0432.CCR-20-2017

  • Precision Medicine and Imaging
    Genomic Characterization of de novo Metastatic Breast Cancer
    Ana C. Garrido-Castro, Liam F. Spurr, Melissa E. Hughes, Yvonne Y. Li, Andrew D. Cherniack, Priti Kumari, Maxwell R. Lloyd, Brittany Bychkovsky, Romualdo Barroso-Sousa, Simona Di Lascio, Esha Jain, Janet Files, Ayesha Mohammed-Abreu, Max Krevalin, Colin MacKichan, William T. Barry, Hao Guo, Daniel Xia, Ethan Cerami, Barrett J. Rollins, Laura E. MacConaill, Neal I. Lindeman, Ian E. Krop, Bruce E. Johnson, Nikhil Wagle, Eric P. Winer, Deborah A. Dillon and Nancy U. Lin
    Clin Cancer Res February 15 2021 27 (4) 1105-1118; DOI:10.1158/1078-0432.CCR-20-1720

  • Precision Medicine and Imaging | AuthorChoice
    Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of “Stemness” Programs and Local Inflammation
    Jorge Barriuso, Raghavendar T. Nagaraju, Shreya Belgamwar, Bipasha Chakrabarty, George J. Burghel, Helene Schlecht, Lucy Foster, Elaine Kilgour, Andrew J. Wallace, Michael Braun, Caroline Dive, D. Gareth Evans, Robert G. Bristow, Mark P. Saunders, Sarah T. O'Dwyer and Omer Aziz
    Clin Cancer Res February 15 2021 27 (4) 1119-1130; DOI:10.1158/1078-0432.CCR-20-3320

  • Precision Medicine and Imaging
    Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains
    Sebastian Klein, Alexander Quaas, Jennifer Quantius, Heike Löser, Jörn Meinel, Martin Peifer, Steffen Wagner, Stefan Gattenlöhner, Claus Wittekindt, Magnus von Knebel Doeberitz, Elena-Sophie Prigge, Christine Langer, Ka-Won Noh, Margaret Maltseva, Hans Christian Reinhardt, Reinhard Büttner, Jens Peter Klussmann and Nora Wuerdemann
    Clin Cancer Res February 15 2021 27 (4) 1131-1138; DOI:10.1158/1078-0432.CCR-20-3596

Translational Cancer Mechanisms and Therapy

  • Translational Cancer Mechanisms and Therapy
    Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo
    Eleni Anastasiadou, Anita G. Seto, Xuan Beatty, Melanie Hermreck, Maud-Emmanuelle Gilles, Dina Stroopinsky, Lauren C. Pinter-Brown, Linda Pestano, Cinzia Marchese, David Avigan, Pankaj Trivedi, Diana M. Escolar, Aimee L. Jackson and Frank J. Slack
    Clin Cancer Res February 15 2021 27 (4) 1139-1149; DOI:10.1158/1078-0432.CCR-20-3139

  • Translational Cancer Mechanisms and Therapy
    ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma
    Yuta Myojin, Takahiro Kodama, Kazuki Maesaka, Daisuke Motooka, Yu Sato, Satoshi Tanaka, Yuichi Abe, Kazuyoshi Ohkawa, Eiji Mita, Yoshito Hayashi, Hayato Hikita, Ryotaro Sakamori, Tomohide Tatsumi, Ayumu Taguchi, Hidetoshi Eguchi and Tetsuo Takehara
    Clin Cancer Res February 15 2021 27 (4) 1150-1161; DOI:10.1158/1078-0432.CCR-20-3382

  • Translational Cancer Mechanisms and Therapy | AuthorChoice
    Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung Adenocarcinoma
    Anneleen Daemen, Jonathan E. Cooper, Szymon Myrta, Matthew J. Wongchenko, Eva Lin, Jason E. Long, Oded Foreman, Zora Modrusan, Jarrod R. Tremayne, Cecile C. de la Cruz, Mark Merchant, Scott E. Martin, Yibing Yan and Melissa R. Junttila
    Clin Cancer Res February 15 2021 27 (4) 1162-1173; DOI:10.1158/1078-0432.CCR-20-1835

  • Translational Cancer Mechanisms and Therapy | AuthorChoice
    Clinical Validation of a Machine-learning–derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer
    Jim P. Abraham, Daniel Magee, Chiara Cremolini, Carlotta Antoniotti, David D. Halbert, Joanne Xiu, Phillip Stafford, Donald A. Berry, Matthew J. Oberley, Anthony F. Shields, John L. Marshall, Mohamed E. Salem, Alfredo Falcone, Axel Grothey, Michael J. Hall, Alan P. Venook, Heinz-Josef Lenz, Anthony Helmstetter, W. Michael Korn and David B. Spetzler
    Clin Cancer Res February 15 2021 27 (4) 1174-1183; DOI:10.1158/1078-0432.CCR-20-3286

  • Translational Cancer Mechanisms and Therapy
    Therapeutic Potential of NTRK3 Inhibition in Desmoplastic Small Round Cell Tumor
    Koichi Ogura, Romel Somwar, Julija Hmeljak, Heather Magnan, Ryma Benayed, Amir Momeni Boroujeni, Anita S. Bowman, Marissa S. Mattar, Inna Khodos, Elisa de Stanchina, Achim Jungbluth, Marina Asher, Igor Odintsov, Alifiani B. Hartono, Michael P. LaQuaglia, Emily Slotkin, Christine A. Pratilas, Sean Bong Lee, Lee Spraggon and Marc Ladanyi
    Clin Cancer Res February 15 2021 27 (4) 1184-1194; DOI:10.1158/1078-0432.CCR-20-2585

  • Translational Cancer Mechanisms and Therapy
    Impact of Body Mass Index on Presence of ctDNA and Disease Recurrence after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Analysis from BRE12-158
    Tarah J. Ballinger, Guanglong Jiang, Nawal Kassem, Milan Radovich and Bryan P. Schneider
    Clin Cancer Res February 15 2021 27 (4) 1195-1199; DOI:10.1158/1078-0432.CCR-20-3341

  • Translational Cancer Mechanisms and Therapy
    Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma
    Yinfei Tan, Eleonora Sementino, Mitchell Cheung, Suraj Peri, Craig W. Menges, Anna-Mariya Kukuyan, Ting Zhang, Vladimir Khazak, Lauren A. Fox, Eric A. Ross, Suresh Ramanathan, Suresh C. Jhanwar, Raja M. Flores, Siddharth Balachandran and Joseph R. Testa
    Clin Cancer Res February 15 2021 27 (4) 1200-1213; DOI:10.1158/1078-0432.CCR-18-3683

Back to top
PreviousNext
Clinical Cancer Research: 27 (4)
February 2021
Volume 27, Issue 4
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

Issue Highlights

  • Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer (NeoSTOP)
  • Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
  • A Phase I Trial of Talimogene Laherparepvec in Combination with Neoadjuvant Chemotherapy for the Treatment of Nonmetastatic Triple-Negative Breast Cancer
  • Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET

Jump to

  • Highlights
  • CCR Translations
  • CCR Perspectives in Regulatory Science and Policy
  • CCR Drug Updates
  • Perspectives
  • Research Briefs: Clinical Trial Brief Report
  • Clinical Trials: Targeted Therapy
  • Clinical Trials: Immunotherapy
  • Precision Medicine and Imaging
  • Translational Cancer Mechanisms and Therapy
Advertisement
  • Most Cited
  • Most Read
Loading
  • FLASH-RT Spares Lung Progenitor Cells
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
  • scRNA-seq Analysis of Gastric Cancer TME
  • PDAC and GATA6 Expression
  • AR Gene Rearrangements in Prostate Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement